Lung Cancer Clinical Trials

Amgen Protocol 20060534 – A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer

Provides information to potential participants on the following clinical trial: Amgen Protocol 20060534 – A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer

Next post in Lung Cancer Clinical Trials